Lucid Diagnostics Announces Peer-Reviewed Publication of Pos

Studies demonstrate real-world clinical utility of EsoGuard testing to detect esophageal precancer
NEW YORK, Dec. 12, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. a commercial-stage, cancer...

Related Keywords

San Antonio , Texas , United States , Natalie Carfora , Pavmed Inc , Lucid Diagnostics Inc , Exchange Commission , Biomedical Research , Nasdaq , Lucid Diagnostics , Risk Patients , San Antonio Firefighter , Real World Experience , Clinical Utility , Interim Data , Digestive Systems , Samples Collected , Antonio Firefighter Study , Esophagus Triage Test , Checkyourfoodtube Precancer Testing , Senior Vice President , Chief Medical Officer , Vice President , Market Access , Esocheck Esophageal Cell Collection Device , Annual Report , Quarterly Report , Markets ,